ChiCTR2200058059
Untitled Trial
A prospective clinical study of Azacitidine combined with or without Venetoclax for the maintenance treatment of post-remission acute myeloid leukemia
Peking University People's Hospital·Phase 1·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Leukemia
Sponsor & location
- Primary sponsor
- Peking University People's Hospital
- Funder
- National Natural Science Foundation of China
- Location
- China
Timeline & enrollment
- Phase
- Phase 1
- Start date
- N/A
- End date
- Dec 31, 2022
ICD-10 classifications
Leukaemia, unspecifiedMyeloid leukaemiaMyeloid leukaemia, unspecifiedOther myeloid leukaemiaMonocytic leukaemia, unspecified
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2200058059
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2200058059 through Pure Global AI's free database. This Phase 1 trial is sponsored by Peking University People's Hospital and is currently Recruiting. The study focuses on Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.